Creo Pharma

Creo Pharma is a UK-based pharmaceutical company specializing in the development, licensing, and distribution of generic and specialty medicinal products. Founded in 2007, the company focuses on providing cost-effective healthcare solutions across various therapeutic areas, including oncology, pain management, and anti-infectives. In 2016, Creo Pharma was acquired by Amneal Pharmaceuticals, a global leader in generics, which significantly expanded its portfolio and market reach in the United Kingdom. The company operates as a key subsidiary for Amneal's UK operations, managing a diverse range of licensed products for the National Health Service (NHS) and retail pharmacy sectors. Its business model emphasizes strategic sourcing and supply chain reliability to ensure the availability of high-quality pharmaceuticals.